166742-75-2 Usage
Uses
Used in Medicinal Chemistry and Drug Discovery:
(R)-N-methyl-1,2,3,4-tetrahydroquinolin-3-amine is utilized as a building block in the synthesis of various bioactive molecules. Its unique structure and chiral properties make it a valuable component in the development of new pharmaceuticals, contributing to the creation of innovative treatments and therapeutic agents.
Used in Pharmaceutical Development:
Due to its ability to interact with biological systems, (R)-N-methyl-1,2,3,4-tetrahydroquinolin-3-amine has potential pharmaceutical uses. The specific stereochemistry of the molecule allows for targeted interactions with biological targets, which can be leveraged to develop drugs with enhanced efficacy and selectivity. This makes it a promising candidate for further research and development in the pharmaceutical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 166742-75-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,6,7,4 and 2 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 166742-75:
(8*1)+(7*6)+(6*6)+(5*7)+(4*4)+(3*2)+(2*7)+(1*5)=162
162 % 10 = 2
So 166742-75-2 is a valid CAS Registry Number.
166742-75-2Relevant articles and documents
HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY
-
, (2008/06/13)
Tricyclic nitrogen containing compounds, having anxiolytic and anti-depressant activity and central nervous system activity of the following structural formula: and pharmaceutically acceptable salts thereof wherein R1 and R2 are inde
Synthesis of the Selective D2 Receptor Agonist PNU-95666E from D-Phenylalanine Using a Sequential Oxidative Cyclization Strategy
Romero, Arthur G.,Darlington, William H.,McMillan, Moses W.
, p. 6582 - 6587 (2007/10/03)
Compound 1 (PNU-95666E) is a selective and high-affinity agonist at the dopamine D2 receptor subtype and is of interest as a potential agent for the treatment of Parkinson's disease. Requiring a synthetic route amenable to scale-up, a synthesis
Heterocyclic amines having central nervous system activity
-
, (2008/06/13)
Tricyclic nitrogen containing compounds, having anxiolytic and anti-depressant activity and central nervous system activity of the following structural formula: STR1 and pharmaceutically acceptable salts thereof wherein R1 and R2 are